As per Market Research Future (MRFR)?s latest analysis, the global neuropathic pain market is set to proliferate at a CAGR of 6.06% during the forecast period 2018 to 2023. The value of the market is poised to grow from USD 5,676.16 Mn in 2017 to USD 8,017.43 Mn in 2023. The rising prevalence of chronic diseases such as diabetes and cancer that triggers neuropathic pain is a major factor responsible for driving the growth of the market.
Vn23
Kudsk Dixon
Blackburn Stilling
Vargas Bond
Ringgaard Lawson
Peterson Didriksen
Duus Moesgaard
Horowitz Holman
Krebs Haahr
Gray Braun